Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/1996
07/03/1996CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors
07/03/1996CN1125575A Adhesion receptor antagonists
07/03/1996CN1032205C Process of preparing purinyl and pyrimidinyl-cyclo butane derivatives
07/02/1996US5532359 Fungicides
07/02/1996US5532248 O-aryl,O-alkyl, and O-alkenyl-macrolides having immunosuppressive activity
07/02/1996US5532233 Platelet activating factor antagonist
07/02/1996US5532221 Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention
07/02/1996US5532215 Antiviral compositions and method of use
07/02/1996US5532214 Anti-HIV protein, TAP 29, from tricosanthes, DNA coding therefor and therapeutic uses thereof
07/02/1996US5532154 Mutated alpha virus
07/02/1996US5532152 Platelet-activating factor acetylhydrolase
07/02/1996US5530966 Protective garment for baseball umpires having an inner cushioned layer and an outer layer of interconnected plates
07/02/1996CA1338432C Esters of 3-demethylthiocolchicine and n-acyl analogs
07/01/1996CA2166371A1 Avian herpesvirus-based live recombinant avian vaccine, in particular against gumboro disease
06/1996
06/27/1996WO1996019580A2 Telomerase protein component
06/27/1996WO1996019498A2 T cell stimulating protein of pestivirus
06/27/1996WO1996019496A1 Variants of human papilloma virus antigens
06/27/1996WO1996019495A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
06/27/1996WO1996019494A1 Peptides having immunomodulatory activity
06/27/1996WO1996019482A1 Thienoxazinone derivatives useful as antiviral agents
06/27/1996WO1996019473A1 New derivatives of pyroglutaminic acid, preparation process and applications
06/27/1996WO1996019472A1 8-alkoxyquinolonecarboxylic acid hydrate with excellent stability and process for producing the same
06/27/1996WO1996019467A1 Substituted thiadiazoles, compositions containing them and their use as antimicrobial and marine antifouling agents
06/27/1996WO1996019460A1 2-carbamoyl-1,4,5,6-tetrahydropyrazines
06/27/1996WO1996019437A1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
06/27/1996DE4446025A1 2-Caroxamido-1,4,5,6-tetrahydropyrazine 2-Caroxamido-1,4,5,6-tetrahydropyrazine
06/27/1996CA2419289A1 Variants of human papilloma virus antigens
06/27/1996CA2208518A1 Substituted thiadiazoles, compositions containing them and their use as antimicrobial and marine antifouling agents
06/27/1996CA2208458A1 Thienoxazinone derivatives useful as antiviral agents
06/27/1996CA2206778A1 Peptides having immunomodulatory activity
06/26/1996EP0718400A2 Methods and compositions for controlling translation of HCV proteins
06/26/1996EP0718296A1 Thermodynamically stable form of N- 4- 2-(2,4-dimethyl phenoxy)-phenyl -2-thiazolyl -1,4,5,6-tetrahydro-2-pyrimidine (DTTP)
06/26/1996EP0717998A1 Use of substance P antagonist for the treatment of pruritis, eye or eyelid pain or disesthesies
06/26/1996EP0717995A2 Cell degeneration suppressing and organ toxicity reducing agent
06/26/1996EP0717777A1 Salmonella vaccines
06/26/1996EP0717774A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella
06/26/1996EP0717752A1 Therapeutic compounds
06/26/1996EP0717750A1 Double-stranded peptide nucleic acids
06/26/1996EP0717738A1 Substituted oxazine and thiazine oxazolidinone antimicrobials
06/26/1996EP0717731A1 Difluoro statone antiviral analogs
06/26/1996EP0717628A1 Nucleosides with anti-hepatitis b virus activity
06/26/1996EP0717622A1 Methods of treating hiv with azaspiranes
06/26/1996EP0696201A4 Supplemented and unsupplemented tissue sealants, methods of their production and use
06/26/1996CN1125479A Ligands for FLT3 receptors
06/26/1996CN1125466A Processes for producing an enzyme
06/26/1996CN1125436A Vitamin D amide derivatives
06/26/1996CN1125400A Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
06/26/1996CN1125138A Chinese proprietary medicine for curing cold
06/25/1996US5530132 Viricides, hiv virus
06/25/1996US5530116 Antimicrobial quinolonyl lactams
06/25/1996US5530103 Method for the purification of PC protein from Borrelia burgdorferi
06/25/1996US5530101 Humanized immunoglobulins
06/25/1996US5530004 Antimycobacterial method
06/25/1996US5529998 Antibacterial medicaments
06/25/1996US5529924 Biologically pure streptomyces microorganism
06/25/1996US5529771 Leukoregulin anti-herpes treatment
06/25/1996US5529770 Viscous liquid conditioning topical germicides
06/24/1996EP0724571A4 Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides
06/20/1996WO1996018641A1 Modulators of the function of fas/apo1 receptors
06/20/1996WO1996018633A1 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
06/20/1996WO1996018628A1 Alkyl substituted piperadinyl and piperazinyl anti-aids compounds
06/20/1996WO1996018600A1 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor
06/20/1996WO1996018419A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c
06/20/1996WO1996018414A1 Acellular anti-bordetella vaccine
06/20/1996WO1996018396A1 Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
06/20/1996WO1996018393A1 Novel compounds
06/20/1996WO1996018391A2 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
06/20/1996WO1996015234A3 Lipid-splitting enzyme
06/20/1996WO1996014314A3 Thiepane compounds inhibiting and detecting hiv protease
06/20/1996WO1996012809A3 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
06/20/1996CA2207029A1 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
06/19/1996EP0717108A1 Recombinant prrs proteins, diagnostic kits and vaccines containing said recombinant proteins
06/19/1996EP0717048A1 Cyclic hexapeptides and their mixings, process to synthesize them and their use
06/19/1996EP0716856A2 Therapeutic uses of 2',5'-oligoadenylate derivatives
06/19/1996EP0716852A1 Pharmaceutical formulations of cefaclor
06/19/1996EP0716693A1 Method and reagent for inhibiting human immunodeficiency virus replication
06/19/1996EP0716613A1 TREATMENT OF $i(H. PYLORI) ASSOCIATED GASTRODUODENAL DISEASE
06/19/1996EP0716605A1 Blocking the accumulation of germs on human cells
06/19/1996EP0716603A1 Methods and compositions for inhibiting uridine secretion
06/19/1996EP0716601A1 Use of thiol compounds in the therapy of viral diseases
06/19/1996EP0535192B1 Novel dna gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same
06/19/1996EP0516725B1 New use of linomide (r)
06/19/1996CN1124980A Modified oligonucleotides having improved anti-influenza activity
06/19/1996CN1124958A Triazole derivative or salt thereof, and fungicide containing the same
06/18/1996US5527910 Bactericides; staphylococcus, streptococcus infections
06/18/1996US5527900 Viricides; anti-htlv activity
06/18/1996US5527829 HIV protease inhibitors
06/18/1996US5527805 Dna-cleaving, cytotoxic and anti-tumor compounds
06/18/1996US5527803 Immunosuppressants, phosphorylase inhibitors
06/18/1996US5527799 HIV protease inhibitors useful for the treatment of AIDS
06/18/1996US5527793 Antibiotic carbapenem compounds
06/18/1996US5527791 Carbapenem antibiotic compounds
06/18/1996US5527781 Aminoglycoside antibiotics
06/18/1996US5527780 Bactericides
06/18/1996US5527776 Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF
06/18/1996US5527703 Genetically engineered proteins for detection of channel modulators, insecticides, anthelmintics
06/18/1996CA2022681C 2-(2-vinylpyrrolidinylthio)carbapenem derivatives
06/18/1996CA2020878C Antitumor antibiotic bu-3285t
06/14/1996CA2158511A1 Pharmaceutical formulations of cefaclor
06/13/1996WO1996017951A2 Identification of genes responsible for in vivo survival of microorganisms